Advertisement

Topics

Melinta To Launch First Commercial Drug Baxdela Independently

12:34 EDT 22 Jun 2017 | SCRIP

Melinta is positioning its novel fluroquinolone antibiotic as an attractive option for seriously ill patients with underlying chronic conditions, but...

      

Related Stories

 

Original Article: Melinta To Launch First Commercial Drug Baxdela Independently

NEXT ARTICLE

More From BioPortfolio on "Melinta To Launch First Commercial Drug Baxdela Independently"

Advertisement
Quick Search
Advertisement
Advertisement